NeurAxis, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from NeurAxis, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Growth Efficiency Ratio: Sales grew 33% in 3 years, but profit fell: $341 less profit per $100 of extra sales. Lower than 93% of Healthcare companies in United States.
Where $100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
-83.3×Over the last 3 years operating cash was negative while the company kept spending on investment (capex).
Lower than 79% of Healthcare companies in United States.
Cash Locked Ratio
$9For every $100 of sales, $9 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $51 from others' credit three years earlier.
Less money tied up than 82% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
2/3 · 2/3Sales grew in 2 of the last 3 years; profit grew in 2 of 3.
Steadier than 69% of Healthcare companies in United States.
Growth Efficiency Ratio
−$341Sales grew 33% in 3 years, but profit fell: $341 less profit per $100 of extra sales.
Lower than 93% of Healthcare companies in United States.
Asset Productivity Ratio
+33% / +333%In 3 years sales changed by +33% while total assets changed by +333%. Assets grew faster than sales.
Balance-sheet strength
Debt Due Cover Ratio
-43.4×Operating cash was negative last year, while some debt falls due within a year.
Lower than 70% of Healthcare companies in United States.
Cash Cushion Ratio
+5%Cash, after subtracting all debt, equals 5% of its market value (net cash).
Lower than 58% of Healthcare companies in United States.
Tangible Assets Ratio
96%Of every $100 the company owns, $96 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 75% of Healthcare companies in United States.
Tangible Net Worth Ratio
92%Of every $100 of net worth, $92 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
More tangible than 75% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (13)
NeurAxis, Inc. made a loss over the last year. NeurAxis, Inc. owes $0.33 for every $1 it owns. NeurAxis, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossNeurAxis, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
14.17The share price is 14.17 times NeurAxis, Inc.'s book value per share, higher than 90% of Healthcare companies in United States.
Market cap
$95 MThe total market value of all of NeurAxis, Inc.'s shares at today's price (share price × number of shares), smaller than 66% of Healthcare companies in United States. PosiCap size class: Micro Cap.
Net worth (book value)
$7 MWhat NeurAxis, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$0.54Net worth divided by the number of shares. The share price of $7.60 is 14.2 times this, which is the P/B above.
Return on equity (ROE)
-139.8%NeurAxis, Inc. lost 139.8% of its shareholders' money over the last year, lower than 78% of Healthcare companies in United States.
Owes vs Owns
0.33×NeurAxis, Inc. owes $0.33 for every $1 it owns (low), lower than 58% of Healthcare companies in United States.
Dividend yield
NoneNeurAxis, Inc. does not currently pay a dividend.
Revenue growth
+33%Revenue rose 33% in the year to Dec 2025, and grew 10% a year on average over 3 years.
Profit growth
LossNeurAxis, Inc. made a loss in each of the last two years.
Profit margin
-218.5%NeurAxis, Inc. lost $219 for every $100 of revenue.
Interest cover
Not coveredNeurAxis, Inc.'s operating profit did not cover its interest costs in the year to Dec 2025.
Cash vs debt
Net cashNeurAxis, Inc. held $5 M more cash than debt (net cash) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For NeurAxis, Inc.: $95 M ÷ $7 M (30 Jun 2026) = 14.2.
What is NeurAxis, Inc.'s return on equity?
NeurAxis, Inc. lost 139.8% of its shareholders' money over the last year, lower than 78% of Healthcare companies in United States.
How much does NeurAxis, Inc. owe compared with what it owns?
NeurAxis, Inc. owes $0.33 for every $1 it owns (low), lower than 58% of Healthcare companies in United States.
Does NeurAxis, Inc. pay a dividend?
No. NeurAxis, Inc. does not currently pay a dividend.
Is NeurAxis, Inc.'s revenue growing?
Revenue rose 33% in the year to Dec 2025, and grew 10% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.